Bandaram Pharma Packtech Ltd
Bandaram Pharma Packtech Ltd (BANDARAM) last reported results for the quarter ended Jun 2026, with sales of ₹23.95 crore and net profit of ₹0.68 crore. The stock last traded at ₹19.9, a market capitalisation of ₹35.7 crore, on a P/E of 36.1. Over the past 52 weeks the stock has ranged between ₹17.2 and ₹49.7. Figures are as of 6 Oct 2026 and are not real time.
Bandaram Pharma Packtech Ltd share price and key metrics
- Current price
- ₹19.9
- Market cap
- ₹35.7 cr
- Stock P/E
- 36.1
- Book value
- ₹14.9
- ROE
- 1.42%
- ROCE
- 4.44%
- Dividend yield
- 0.00%
- 52w high / low
- 49.7/17.2
Metrics as of 6 Oct 2026. Not real time.
Track Bandaram Pharma Packtech Ltd
Cruxal reads every Bandaram Pharma Packtech Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Bandaram Pharma Packtech Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 50%
- TTM
- 134%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 26%
- TTM
- 19%
- 10 Years
- 24%
- 5 Years
- %
- 3 Years
- -12%
- 1 Year
- -39%
- 10 Years
- %
- 5 Years
- 5%
- 3 Years
- 6%
- Last Year
- 1%
Bandaram Pharma Packtech Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹23.95 cr, up 195.7% from ₹8.1 cr a year earlier. Net profit was ₹0.68 cr, up 3300.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 7.11 | 10 | 8.49 | 8.1 | 13.72 | 14.84 | 26.26 | 23.95 |
| Expenses | 6.02 | 9.34 | 7.95 | 7.47 | 13.27 | 13.84 | 25.44 | 22.4 |
| Operating profit | 1.09 | 0.66 | 0.54 | 0.63 | 0.45 | 1 | 0.82 | 1.55 |
| OPM % | 15.33% | 6.60% | 6.36% | 7.78% | 3.28% | 6.74% | 3.12% | 6.47% |
| Other income | 0 | 0 | 0.09 | 0 | 0.01 | 0 | 0.01 | 0 |
| Interest | 0.26 | 0.24 | -0.1 | 0.46 | 0.25 | 0.33 | 0.46 | 0.42 |
| Depreciation | 0.15 | 0.15 | 0.53 | 0.13 | 0.14 | 0.14 | 0.25 | 0.2 |
| Profit before tax | 0.68 | 0.27 | 0.2 | 0.04 | 0.07 | 0.53 | 0.12 | 0.93 |
| Tax % | 0.00% | 103.70% | 25.00% | 25.00% | 28.57% | 33.96% | 25.00% | 25.81% |
| Net profit | 0.67 | -0.02 | 0.15 | 0.02 | 0.06 | 0.35 | 0.09 | 0.68 |
| EPS (₹) | 0.56 | -0.01 | 0.12 | 0.02 | 0.02 | 0.11 | 0.05 | 0.38 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Bandaram Pharma Packtech Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 0 | 18.73 | 34.08 | 36.96 | 62.92 | 78.77 |
| Operating profit | -0.01 | 1.15 | 2.82 | 2.83 | 2.91 | 3.82 |
| OPM % | — | 6.14% | 8.27% | 7.66% | 4.62% | 4.85% |
| Net profit | -0.01 | 0.26 | 0.95 | 0.99 | 0.28 | 1.18 |
| EPS (₹) | -0.01 | 0.12 | 0.79 | 0.82 | 0.16 | 0.56 |
TTM is the trailing twelve months to the most recent quarter.
Bandaram Pharma Packtech Ltd balance sheet
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 7.06 | 3.00 | 12.00 | 12.00 | 17.97 |
| Reserves | -0.06 | 0.08 | 0.28 | 0.65 | 8.81 |
| Borrowings | 0.00 | 14.20 | 12.20 | 17.15 | 23.95 |
| Other liabilities | 0.48 | 2.90 | 7.58 | 9.12 | 25.13 |
| Total liabilities | 7.48 | 20.18 | 32.06 | 38.92 | 75.86 |
| Fixed assets | 2.87 | 5.03 | 4.48 | 3.95 | 15.22 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.09 | 0.00 | 1.40 | 1.40 | 0.00 |
| Other assets | 2.52 | 15.15 | 26.18 | 33.57 | 60.64 |
| Total assets | 7.48 | 20.18 | 32.06 | 38.92 | 75.86 |
As reported by the company. Total assets equal total liabilities by construction.
Bandaram Pharma Packtech Ltd cash flow
| ₹ crore | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from operations | -1.10 | -4.13 | -4.93 | -4.92 |
| Cash from investing | -5.30 | -1.58 | -0.08 | 0.00 |
| Cash from financing | 4.47 | 5.59 | 5.09 | 5.53 |
| Net cash flow | -1.93 | -0.11 | 0.08 | 0.60 |
| Free cash flow | -3.89 | -4.31 | -5.01 | -4.92 |
| CFO / operating profit | -96% | -139% | -163% | -169% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Bandaram Pharma Packtech Ltd operating ratios
| Per year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROCE % | 5.69% | 9.10% | 7.67% | 4.44% |
| Debtor days | 129.01 | 155.51 | 185.27 | 181.86 |
| Cash conversion cycle | 129.01 | 155.51 | 185.27 | 181.86 |
| Working capital days | 147.13 | 147.59 | 165.22 | 127.27 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Bandaram Pharma Packtech Ltd shareholding pattern
Promoters held 62.66% at Jun 2026, down from 75.00% at Jun 2025. DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 62.62% | 62.66% | 62.66% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 24.99% | 25.00% | 24.99% | 24.99% | 25.00% | 37.37% | 37.34% | 37.33% |
| No. of shareholders | 4,634 | 4,767 | 4,827 | 4,889 | 4,955 | 5,095 | 5,078 | 5,103 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Bandaram Pharma Packtech Ltd corporate filings
- Certificate under Regulation 74(5) of SEBI (DP) Regulations,2018Company Updatelow impact
- Company: Bandaram Pharma Packtech Limited - Board Meeting Scheduled for 30.09.2026 CancelledCompany Updatelow impact
Cruxal's analysis: This announcement pertains solely to the cancellation of a scheduled board meeting on…
Read the full analysis - Bandaram Pharma Packtech Limited Announces Board Meeting to Consider Scheme of Arrangement or AmalgamationBoard Meetinghigh impact
Cruxal's analysis: Bandaram Pharma Packtech Limited has scheduled a Board of Directors meeting for September…
Read the full analysis - Bandaram Pharma Packtech Limited announces successful conclusion of Annual General Meeting for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: Bandaram Pharma Packtech Limited has formally concluded its Annual General Meeting held…
Read the full analysis - Bandaram Pharma Packtech Limited concludes Annual General Meeting for FY 2025-26 with all resolutions passedAGM/EGMlow impact
Cruxal's analysis: Bandaram Pharma Packtech Limited has successfully concluded its Annual General Meeting…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
- Bandaram Pharma Packtech Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Bandaram Pharma Packtech Ltd has filed its Annual Report for the financial year 2025-26…
Read the full analysis - Bandaram Pharma Packtech Limited Announces Rescheduled Annual General Meeting for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: Bandaram Pharma Packtech Limited has issued a notice for its Annual General Meeting (AGM)…
Read the full analysis - Bandaram Pharma Packtech Limited Reports Q1 FY2027 Financial Results and Announces AGM DateResultmedium impact
Cruxal's analysis: Bandaram Pharma Packtech Limited reported Q1 FY2027 standalone revenue of 2 crore 98 lakh…
Read the full analysis - Bandaram Pharma Packtech Limited schedules Board Meeting for August 13, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Bandaram Pharma Packtech Limited has formally intimated the BSE regarding a Board of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.